22 reports

  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Malaria
  • World
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma
  • Other Significant Developments

Summary Wellcome Trust (Wellcome) is a charity that funds research organizations and research communities.It offers funding schemes to support individual researchers, teams and resources. The trust provides funds in areas of biomedical science, public engagement, humanities, innovations, social science, population...

  • Malaria
  • United Kingdom
  • United States
  • World
  • Wellcome Trust
  • Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma
  • May 01, 2018: $4.6M boost in search for new malaria drugs

Wellcome Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company report...

  • Malaria
  • Japan
  • United Kingdom
  • World
  • Wellcome Trust
  • MBIO DIAGNOSTICS INC PIPELINE PRODUCTS BY INDICATION
  • NOV 04, 2014: MBIO DIAGNOSTICS AWARDED CONTRACT FOR DIAGNOSTIC DEVELOPMENT WITH THE U.S. ARMY

Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions.The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a single sample.The...

  • Diagnostics
  • Malaria
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE

Malaria - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Pipeline Review, H1 2018, provides an overview of the Malaria (Infectious Disease) pipeline landscape. Malaria is a life-threatening blood disease caused...

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.
  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE

Malaria - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Pipeline Review, H2 2017, provides an overview of the Malaria (Infectious Disease) pipeline landscape. Malaria is a life-threatening blood disease caused...

  • Antimalarials
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.
  • Medicines for Malaria Venture, Key Competitors
  • Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab

Summary Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs.The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, safety in small children,...

  • Malaria
  • Switzerland
  • United States
  • Company Operations
  • Eisai Co., Ltd.
  • MBIO DIAGNOSTICS INC PIPELINE PRODUCTS BY INDICATION
  • MBIO DIAGNOSTICS, INC. PIPELINE PRODUCTS SUMMARY BY DEVELOPMENT STAGE

Summary MBio Diagnostics, Inc. (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio array system, a fluorescence immunoassay system that provides the simultaneous and accurate measurement of multiple analytes from a single sample. It offers LightDeck technologies...

  • Diagnostics
  • Malaria
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • APR 02, 2018: UNC RELEASES HUGE DATABASE OF MOLECULES TO SUPPORT ARTIFICIAL INTELLIGENCE METHODS IN CHEMISTRY

Investment in Tuberculosis Countering the Rise of Drug-resistant Tuberculosis The data and analysis within this report is driven by GlobalData.

  • Malaria
  • Pharmaceutical
  • Therapy
  • United States
  • Audentes Therapeutics, Inc.
  • DEC 02, 2016: ACCESS BIO RECIEVED A USD $3.7 MILLION GRANT FROM THE BILL & MELINDA GATES FOUNDATION
  • DEC 02, 2016: ACCESS BIO RECIEVED A USD $3.7 MILLION GRANT FROM THE BILL & MELINDA GATES FOUNDATION

## Scrub Typhus Infection ## Sexually Transmitted Disease ## Tuberculosis ## Tumor ## Avellino Corneal Dystrophy ## Chlamydia Infection ## Congenital Adrenal Hyperplasia ## Flu ## G##PD Deficiency ## Influenza A

  • In Vitro Diagnostics
  • Infectious Disease
  • Malaria
  • Molecular Diagnostic
  • United States
  • MALARIA - PIPELINE BY IMMUNOVACCINE INC
  • MALARIA - PIPELINE BY PROTEIN POTENTIAL LLC

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Malaria
  • East Asia
  • Japan
  • United States
  • Product Initiative
  • FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS, MAJOR PRODUCTS AND SERVICES

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Diagnostics
  • Malaria
  • Africa
  • India
  • GlobalData's company

Tuberculosis is one of the three most prevalent infectious diseases in the world.

  • Malaria
  • Japan
  • United Kingdom
  • Company
  • Eiken Chemical Co., Ltd.
  • Clinical Trial profile. 1784 Trial Title
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Parasitic Diseases Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Parasitic Diseases Global Clinical Trials Review, H1, 2018" provides an overview of Parasitic Diseases clinical trials scenario.This report provides top line data relating to the clinical trials...

  • Drug Discovery And Development
  • Infectious Disease
  • Malaria
  • World
  • GlaxoSmithKline plc

HIV/ AIDS is the leading cause of deaths of over ##. ## million people every year; and malaria and tuberculosis together cause deaths of an estimated ##. ## million people.

  • Gene Therapy
  • Malaria
  • Pharmaceutical
  • Vaccine
  • GenVec, Inc.
  • FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • INFECTION DETECTION TEST - P. FALCIPARUM - PRODUCT STATUS

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Clinical Trial
  • Malaria
  • Point Of Care Testing
  • United States
  • GlobalData's company
  • Eisai Co., Ltd. - Discovery, 2016

Eisai Co., Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Eisai Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Eisai Co., Ltd.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by...

  • Cancer
  • Malaria
  • Research And Development
  • Therapy
  • Eisai Co., Ltd.
  • DESIGNMEDIX ENTERS INTO AGREEMENT WITH THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Malaria
  • Pathology
  • United States
  • Deals & Alliance
  • DesignMedix
  • THROMBOSIS
  • ASTRAZENECA PLC - DISCOVERY, 2016

The scientists reported ##, ##-azaindoles as a new inhibitor class that killed Mycobacterium tuberculosis in vitro and demonstrated efficacy in mouse tuberculosis models.

  • Blood Disease
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC

These include tuberculosis, one of the top ten causes of death worldwide, infecting ##. ## million and killing ##. ## million people in 2016 alone, and gonorrhoea, the sexually transmitted disease that infects ## million people a year and is now becoming extremely difficult to treat.

  • Genetic
  • Malaria
  • United Kingdom
  • World
  • Thermo Fisher Scientific, Inc.
  • Cellceutix Corporation - Dormant Developmental Projects,2016

Cellceutix Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Cellceutix Corporation - Product Pipeline Review - 2016’, provides an overview of the Cellceutix Corporation’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics...

  • Malaria
  • Research And Development
  • United States
  • Company Operations
  • Cellceutix Corporation
  • Official Title
  • Clinical Trial Profile Snapshots

Malaria Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H1, 2016" provides an overview of Malaria clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes an overview of trial numbers...

  • Clinical Trial
  • Infectious Disease
  • Malaria
  • Pharmaceutical
  • World